ロード中...
IL-27 Is Essential for Suppression of Experimental Allergic Asthma by the TLR7/8 Agonist R848 (Resiquimod)
Different models of experimental allergic asthma have shown that the TLR7/8 agonist resiquimod (R848) is a potential inhibitor of type 2 helper cell–driven inflammatory responses. However, the mechanisms mediating its therapeutic effects are not fully understood. Using a model of experimental allerg...
保存先:
| 出版年: | J Immunol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AAI
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5114883/ https://ncbi.nlm.nih.gov/pubmed/27799314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1601094 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|